BSE Live
Oct 30, 11:48Prev. Close
296.70
Open Price
295.00
Bid Price (Qty.)
290.10 (1)
Offer Price (Qty.)
293.95 (800)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Samrat Pharmachem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 9.89 | 2.52 | 22.53 | 23.60 | 7.34 | |
| Net CashFlow From Operating Activities | -10.09 | 9.41 | -9.44 | 17.78 | 4.83 | |
| Net Cash Used In Investing Activities | 0.00 | -0.41 | -3.01 | -1.37 | -2.92 | |
| Net Cash Used From Financing Activities | 0.48 | -11.20 | 9.60 | -1.95 | -1.89 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -9.62 | -2.19 | -2.84 | 14.46 | 0.02 | |
| Cash And Cash Equivalents Begin of Year | 9.67 | 11.86 | 14.71 | 0.24 | 0.26 | |
| Cash And Cash Equivalents End Of Year | 0.05 | 9.67 | 11.86 | 14.70 | 0.28 |
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y